Entrada Therapeutics Inc (TRDA) Financials

$7.15

$-0.37 (-4.92%)

As on 09-Sep-2026 13:36EDT

Market cap

$278 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

1.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	4.69	25.42	210.78	129.01	25.26	--
Cost of Revenue	40.05	4.10	3.77	99.88	1.90	1.12
Gross Profit	-35.37	21.33	210.78	129.01	-1.90	-1.12
Operating Expenses	141.16	177.32	163.77	132.18	97.25	51.13
Operating Profit (EBIT)	-176.53	-156.00	47.01	-3.16	-97.25	-51.13
Other Income	--	--	--	--	--	-0.03
Profit before Tax	-164.96	-142.83	66.49	12.06	-94.62	-51.16
Provision for Tax	0.82	0.92	0.86	18.74	-7.16	-1.09
Profit after Tax (Net Income)	-165.78	-143.75	65.63	-6.69	-87.46	-50.07
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-94.62	-51.16

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	233.41	306.13	428.68	242.36	212.55	298.72
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	44.10	46.79	58.16	68.04	17.53	0.40
Current Liabilities	21.37	24.45	39.48	158.80	21.97	6.72
Total Liabilities	320.25	377.38	526.32	469.19	252.06	305.83

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	66.17	71.13	86.28	99.42	42.18	7.13
Current Assets	232.70	306.25	440.04	369.77	209.88	298.70
Total Assets	320.25	377.38	526.32	469.19	252.06	305.83
Total Debt*	48.54	50.93	59.21	68.23	25.94	--
Net Current Assets	211.33	281.80	400.56	210.98	187.90	291.98

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-128.51	-41.56	139.80	-93.79	-50.86
Cash Flow from Investing Activities	--	116.81	-27.80	-138.40	-148.65	-4.58
Cash from Financing Activities	--	0.89	102.96	21.04	0.48	307.46
Net Cash Inflow / Outflow	--	--	--	--	--	252.02

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-3.97	-3.47	1.52	-0.20	-2.79	-2.41
Cash EPS ($)	--	-3.38	1.61	-0.12	-2.73	-2.36
Adjusted Book Value ($)	--	7.40	9.96	7.26	6.78	14.38
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.11	-0.97	4.19	-2.99	-2.45
Free Cash Flow per Share ($)	--	-3.13	-1.04	4.02	-3.08	-2.67

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-34.03	16.44	-2.43	-32.56	-38.93
ROE (%)	-61.45	-39.13	19.56	-2.94	-34.21	-38.93
ROA (%)	-42.03	-31.81	13.18	-1.85	-31.35	-28.66
EBIT Margin (%)	-3,520.25	-561.84	31.54	9.34	-384.99	--
Net Margin (%)	-3,537.73	-565.48	31.13	-5.18	-346.23	161,522.58
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-94.10	-0.88	0.63	4.11	--	--
EBIT Growth (%)	-114.50	-314.82	451.47	112.40	-90.21	-92.76
Net Profit Growth (%)	-126.00	-319.04	1,081.69	92.36	-74.66	-88.79
EPS Growth (%)	-122.70	-3.28	8.61	0.93	-0.16	-0.86
Book Value Growth (%)	-39.78	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-2.96	11.34	-75.32	-4.85	-7.10
Price / Book Value	1.22	1.39	1.74	2.08	1.99	1.19
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.59	-1.27	5.46	14.75	-2.74	-1.29
Close Price ($)	7.36	10.28	17.29	15.09	13.52	17.12
High Price ($)	16.45	18.76	21.79	18.44	24.38	36.85
Low Price ($)	4.93	4.93	11.35	9.32	5.12	13.27
Market Cap ($ Cr)	277.62	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.17	0.14	0.28	0.12	--
Short term debt to equity ratio	0.02	0.01	0.02	0.03	0.04	--
Current Ratio	10.89	12.53	11.15	2.33	9.55	44.46
Quick Ratio	10.89	--	--	2.33	--	--
Interest Coverage	--	--	--	--	-36.95	-1,649.26

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	17.41	10.14	1.75	4.56	--	--
Asset Turnover	0.01	0.06	0.42	0.36	0.09	--
Receivable days	--	44.95	8.28	16.64	12.61	--
Inventory Days	--	--	0.00	0.00	--	--
Payable days	--	291.95	364.77	16.94	645.31	377.35
Cash Conversion Cycle	--	--	-356.48	-0.30	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.